Adage Capital Partners Gp, L.L.C. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Adage Capital Partners Gp, L.L.C.

$52.3 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $106 Million - $111 Million	-731,078 Reduced 24.06%	2,308,014 $349 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $237 Million - $416 Million	2,849,092 Added 1499.52%	3,039,092 $443 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $8.26 Million - $10.7 Million	75,000 Added 65.22%	190,000 $22.5 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $5.49 Million - $8.17 Million	55,000 Added 91.67%	115,000 $15.8 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $5.93 Million - $8.33 Million	60,000 New	60,000 $8.34 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $4.6 Million - $7.35 Million	-70,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $5.13 Million - $7.34 Million	-80,000 Reduced 53.33%	70,000 $4.79 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $19.5 Million - $29.5 Million	-300,000 Reduced 66.67%	150,000 $12.9 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $14.8 Million - $19.5 Million	250,000 Added 125.0%	450,000 $29.3 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $87,755 - $224,545	3,025 Added 1.54%	200,000 $14.6 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $19.3 Million - $40.3 Million	-703,025 Reduced 78.11%	196,975 $6.7 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $27.6 Million - $38.9 Million	-675,000 Reduced 42.86%	900,000 $49 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $11.2 Million - $14.8 Million	300,000 Added 23.53%	1,575,000 $65.7 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $23.9 Million - $40.2 Million	600,000 Added 88.89%	1,275,000 $55.8 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $6.04 Million - $9.33 Million	175,000 Added 35.0%	675,000 $34.7 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $14.9 Million - $21.5 Million	500,000 New	500,000 $18.5 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account